Use Case Selection and Sequencing
Choosing capabilities where AI adds value over simpler approaches, with a defined action following the output and a user positioned to act on it.
Custom Software
Hire Healthcare AI Product Managers
Healthcare AI product managers decide which AI capabilities are worth building, define what adequate output means, and own the workflow decisions that determine adoption. They select use cases against clinical value and feasibility, establish acceptance criteria with clinicians, and place human review where it protects patients without making the product unusable.
The role exists because AI product decisions are unusually easy to get wrong. A demonstration convinces stakeholders, funding follows, and nobody has established what quality bar the output must clear or where the clinician sits in the loop. Those decisions belong to a product owner before engineering begins. Taction Software staffs accordingly, and our hire dedicated developers hub covers the engineering roles.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Healthcare AI Product Managers Own
The output is decisions and definitions rather than specifications alone. Which use case, what quality bar, where review sits, and what would constitute failure are the questions that determine whether a capability reaches daily use. The work below reflects that. Use case selection appears first because most AI disappointment traces to building the wrong thing competently.
Quality Bar Definition With Clinicians
Establishing what output is good enough before development, since a bar set after seeing results describes what was built rather than what was needed.
Human Review Placement
Deciding where a person checks output, balancing safety against workflow cost, since review nobody has time for is not review.
Workflow Integration Decisions
Determining where capability appears in clinical work, which affects adoption more than output quality does in most deployments.
Adoption and Override Measurement
Defining what will be measured after launch, including edit and rejection rates, since usage counts do not distinguish adoption from clicking past a feature.
Stopping and Withdrawal Criteria
Establishing in advance what results would end the effort, so a capability that does not work can be withdrawn without relitigating the original decision.
Healthcare Context This Role Requires
AI product management in healthcare requires clinical judgment about consequence and enough technical literacy to know what is buildable. A product manager who cannot read an evaluation report will accept a capability nobody measured. One without clinical grounding will place review where it obstructs care. The context spans our healthcare software work.
01
Demonstrations Mislead Consistently
A working prototype establishes feasibility on selected examples. It says nothing about performance at volume on unselected cases, which is what deployment involves.
02
The Action Determines the Value
A prediction nobody acts on produces nothing. Use case selection should start from the decision that would change rather than from available data.
03
Review Placement Is a Product Decision
Where the human sits determines safety and workflow cost simultaneously. Deferring it to engineering produces defaults that satisfy neither concern.
04
Clinician Time Is the Scarce Resource
Capabilities adding seconds to frequent tasks fail regardless of quality. Adoption depends on net time saved rather than on output impressiveness.
05
Quality Bars Must Precede Development
Criteria established after results describe the model. Fixing them beforehand with clinical input is what allows an honest decision about whether to proceed.
06
Product Managers Do Not Make Clinical Determinations
The role defines requirements and criteria with clinical input. Clinical decisions about care remain with clinicians, and the product must preserve that.
Skills This Role Requires
This is product management with technical literacy and clinical grounding. The differentiating skill is judgment about what not to build, since AI enthusiasm generates more proposals than any organization can validate. The competencies below reflect that. Weight evaluation literacy and clinical facilitation above delivery process familiarity.
Evaluation Report Literacy
Reading model evaluation critically, recognizing where subgroup analysis is missing and where results reflect selected rather than representative data.
Clinical Workflow Observation
Watching how work actually happens before deciding where capability belongs, since documented process and real process differ in the ways that matter.
Acceptance Criteria Facilitation
Working with clinicians to define adequate output, translating clinical judgment into criteria engineers can test against.
Feasibility Assessment With Engineering
Distinguishing what is buildable from what demonstrates well, working with engineering to identify where data or evaluation constraints block a use case.
Adoption Instrumentation Definition
Specifying what post-launch measurement will capture, following the delivery discipline described in our development process.
Stakeholder Management Across Functions
Working across clinical, technical, compliance, and executive groups whose priorities conflict, surfacing disagreement rather than deferring it into the build.
How We Evaluate AI Product Managers
The distinguishing question is what they killed. Product managers who advanced every proposal have not exercised the judgment the role exists to provide. Our assessment centers on use case selection, quality bar discipline, and adoption measurement. Our delivery process includes review points where you can reassess fit.
A Use Case They Stopped
We ask about AI they recommended not building. Product managers who never declined one advanced proposals rather than evaluating them.
Quality Bar Sequence
We ask when acceptance criteria were set. Criteria established after seeing output describe the result rather than defining the requirement.
Adoption Versus Usage Measurement
We ask what they measured after launch. Invocation counts cannot distinguish clinicians using a capability from clinicians dismissing it.
Review Placement Reasoning
We ask how they decided where the human sits. Product managers who deferred this to engineering allowed defaults to determine safety posture.
Workflow Observation Practice
We ask what they learned watching clinicians work. Product decisions made from stakeholder description miss the workarounds that determine adoption.
Verified Product Experience
We describe which AI products each manager owned and what reached daily use. We do not claim clinical or product certifications for managers who lack them.
Engagement Options for Product Leadership
Engagements are usually shorter than engineering ones, since the role front-loads decisions. Structures below reflect that, and our engagement models accommodate advisory or embedded arrangements.
Use Case Assessment and Sequencing
Evaluating proposed AI capabilities against clinical value, feasibility, and available action, producing a prioritized recommendation including what to decline.
A Product Manager Through Definition
Owning use case definition, quality bars, and workflow decisions through the point where engineering can build, then handing to your team.
Embedded Product Ownership
Where you lack internal AI product capability, an embedded manager owns the capability through launch and adoption measurement.
Augmenting Your Product Function
Where you own product direction, staff augmentation adds AI-specific product capacity within your existing prioritization and governance.
Full Team With Product Included
A dedicated healthcare development team includes product ownership alongside engineering, which suits organizations without internal AI product capability.
Comparison of Build Versus Buy
Assessing whether commercial products meet the need, drawing on considerations covered in our in-house versus outsourced development analysis.
Tell Us What You Are Being Asked to Build
Share the AI proposals in front of you and who is asking. Use case assessment frequently establishes that several should not proceed.
Decision Authority, Safety, and Boundaries
Product management defines requirements and criteria. Clinical decisions about care and organizational decisions about adoption belong elsewhere. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified. Where intended use may create diagnostic or treatment claims, SaMD classification is assessed during discovery with your regulatory advisors.
01
Clinical Stakeholders Set the Quality Bar
Product managers facilitate and document. What constitutes clinically adequate output is determined by clinicians rather than by product judgment.
02
Human Review Is Not Optional
Where output influences care, review placement is a requirement rather than a tradeoff. Product decisions may adjust where, not whether.
03
Stopping Criteria Defined in Advance
Every capability has documented conditions under which it would be withdrawn, so failure produces a decision rather than a debate about original intent.
04
Adoption Measured Honestly
Override and abandonment rates are reported alongside usage, since a capability clinicians dismiss should not be presented as adopted.
05
Sensitive Application Judgment
Capabilities affecting behavioral health populations warrant additional caution. We built CHIPSS, a behavioral health system, where such judgment was foundational.
06
Products We Would Not Define
We would not define capabilities that place clinical determinations in software, remove human review to improve throughput, or ship without adoption measurement.
Cost to Engage Product Leadership
Product engagements are smaller than build engagements and reduce build cost by preventing work on capabilities that should not proceed. The tiers below describe build engagements product ownership informs. We publish no figures on adoption or value, because those depend on your workflows and clinicians.
MVP or Single Module
$40,000 to $80,000
Product ownership within a first AI build, covering use case definition, quality bars with clinical input, workflow placement, and adoption instrumentation.
Full Platform Build
$80,000 to $200,000
Product leadership across several capabilities with portfolio sequencing, shared quality standards, workflow decisions, and adoption measurement.
Enterprise Deployment
Starting at $200,000
Multi-facility AI programs with governance participation, stakeholder coordination across sites, and product ownership spanning several clinical environments.
Discovery Phase Scoping
Discovery is paid and time-boxed. It produces a use case assessment with recommendations including declines, feasibility findings, and an itemized fixed-scope estimate.
Cost Drivers to Expect
Proposal volume, clinical stakeholder availability, workflow observation scope, feasibility assessment depth, governance participation, and site variation.
Ongoing Support Costs
Capabilities need product attention after launch. Budget for adoption review, quality bar reassessment, and decisions about continuation as results accumulate.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Why Engage Product Leadership Through Taction
Two questions matter. Whether the product manager will decline use cases, and whether they set quality bars before development. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age.
We Build What We Define
Product decisions are made by people who have shipped clinical AI and know what proves difficult, rather than by advisors who hand specifications to someone else.
Clinical Systems Built From the Inside
We built Voyant Health, an EHR platform, and CHIPSS, a behavioral health system, which informs where capability can realistically sit in clinical workflow.
Experience Under Regulatory Registration
We built Revive Ease and PainKare, both FDA-registered applications. That work informs how we treat intended use in product definition.
ISO 27001 Certified Security Management
Taction Software holds ISO 27001 certification covering our information security management practices, described further under our certifications and compliance information.
We Decline Use Cases Regularly
Assessment usually identifies proposals that should not proceed. Saying so reduces the engineering work available to us and is the point of the role.
We Will Recommend Buying Instead
Where a commercial product meets the need, integrating it costs less than building. That recommendation removes the larger build from our scope.
FAQs
Frequently Asked Questions
We assess the proposals in front of you against clinical value and feasibility, then present product managers with healthcare AI experience for your approval.
Product ownership within a build falls in the $40,000 to $80,000 range, portfolio leadership $80,000 to $200,000, and enterprise programs start at $200,000. Advisory-only engagements are smaller and scoped as discovery.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
Clinicians, working with the product manager who documents the criteria. Quality bars are set before development so the decision to proceed rests on evidence.
Through override and abandonment measurement rather than invocation counts, since clinicians dismiss capabilities they cannot use while usage statistics continue rising.
Analysts define what a system must do and how completion is verified. AI product managers additionally decide which capabilities are worth building and what quality bar applies.
Share the AI proposals you are evaluating, who is requesting them, your clinical stakeholder availability, your workflow constraints, and the engagement model you have in mind. We will assess use cases and recommend declining those that should not proceed. We do not promise instant matching or guaranteed adoption.